Carbapenems [DG:DG01458] are a class of beta-lactam antibiotics often used as the last resort treatment for severe bacterial infections. Thus, the appearance of carbapenem resistance caused by acquisition of carbapenem-hydrolyzing beta-lactamases (carbapenemases), especially among Enterobacteriaceae, Pseudomonas and Acinetobacter, is considered as a global health threat.
